The drug discovery company, e-Therapeutics plc, has appointed Steve Self to its board as an executive director, with oversight of development. Mr. Self will be charged with responsibility for supervising the company’s proprietary portfolio of drug candidates. He began his career in 1975 with The Wellcome Foundation before going on to work for Boots Healthcare International and Merck Generics, which was sold to Mylan in 2007.
Copyright 2010 Evernow Publishing Ltd